Triple Therapy or Triple threat? Balancing the risks of antithrombotic therapy for patients with atrial fibrillation and coronary stents

被引：14
|
作者：
Francescone, Steven [1 ]
Halperin, Jonathan L. [1 ]
机构：
[1] Mt Sinai Hosp, Med Ctr, Cardiovasc inst, New York, NY 10029 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2008年 / 51卷 / 08期
关键词：
D O I：
10.1016/j.jacc.2007.11.034
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：826 / 827
页数：2
相关论文
共 50 条
  • [21] Comparison of triple antithrombotic therapy and dual antiplatelet therapy for patients with atrial fibrillation after percutaneous coronary stenting
    Fan, Xiaoying
    Zhang, Yao
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 29 (05) : 1769 - 1773
  • [22] Triple, dual, and single antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention
    Yuichi Saito
    Yoshio Kobayashi
    Cardiovascular Intervention and Therapeutics, 2020, 35 : 44 - 51
  • [23] Triple, dual, and single antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention
    Saito, Yuichi
    Kobayashi, Yoshio
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2020, 35 (01) : 44 - 51
  • [24] Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention
    Saito, Yuichi
    Kobayashi, Yoshio
    JOURNAL OF CARDIOLOGY, 2019, 73 (1-2) : 1 - 6
  • [25] CLOPIDOGREL AND COUMADIN THERAPY COMPARED TO TRIPLE ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION AFTER PERCUTANEOUS CORONARY INTERVENTION
    Badri, Vinil Kumar
    Kodumuri, Vamsi
    Singh, Param
    Khosla, Sandeep
    Arora, Rohit
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A413 - A413
  • [26] Triple Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: a Fading Role
    Dimitrios Alexopoulos
    Panagiotis Vlachakis
    John Lekakis
    Cardiovascular Drugs and Therapy, 2017, 31 : 319 - 324
  • [27] Triple Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: a Fading Role
    Alexopoulos, Dimitrios
    Vlachakis, Panagiotis
    Lekakis, John
    CARDIOVASCULAR DRUGS AND THERAPY, 2017, 31 (03) : 319 - 324
  • [28] Outcomes of Rivaroxaban as Part of Triple Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention
    Alshahrani, Asma
    Alshareef, Hanan
    Alanazi, Zaid
    Alsawaq, Enas
    LATIN AMERICAN JOURNAL OF PHARMACY, 2022, 41 (05): : 917 - 922
  • [29] Acute Coronary Syndrome in Patients With Atrial Fibrillation What Is the Benefit/Risk Profile of Triple Antithrombotic Therapy?
    Maggioni, Aldo Pietro
    CIRCULATION, 2012, 126 (10) : 1176 - 1178
  • [30] Double or triple antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention: not a matter of faith
    Galli, Mattia
    Andreotti, Felicita
    D'Amario, Domenico
    Crea, Filippo
    Porto, Italo
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (03) : E16 - E17
12345